Exhibition

Exhibiting at the 14th European Congress on Biotechnology offers the opportunity to meet and do business with Leading biotechnologists from around the world, biotech CEOs & entrepreneurs, pharma executives, leaders from society, industry and government, innovative biotech researchers and young biotechnologists, European & international policy makers, and other key biotechnology stakeholders. Spaces are limited and will be allocated on a first come first served basis.

Exhibition packages comprise the following:

  • Free Registration (number of free registrations depend on the size of the stand)
  • Company Presentation
  • Partnering
  • Company Profile in Exhibition Guide
  • Listing in online & printed Exhibitors list

Company Presentations

In addition to the stand exhibition, through special 15 minute lunchtime oral presentation sessions, Companies have the opportunity not only to present their science, technologies & services but also to attract partnering, marketing or investment openings. These presentations are an ideal opportunity to target your company's science and activities to one of the broadest cross-sections of the European biotechnology research community, including young and up-coming talent.

Presentations should be focused on:

  • Company overview, including products on the market,
  • Key technologies or services,
  • Product development,
  • Existing alliances,
  • Type of alliance sought.

To see the online exhibition map and reserve your exhibition space now, click here


EXHIBITOR OPTIONS
EXHIBITION, book your stand now at www.ecb14.eu
  Registrations   Price
Stand 2 x 3 (6 m2) 2 €2,500
Stand 3 x 3 (9 m2) 3 €3,200
Stand 5 x 5 (25 m2) 5 €7,500
Stand 7 x 7 (49 m2) 6 €13,000

Exhibition prices include listing in online & print Exhibitors List


Company Presentations

Exhibiting Biotechnology Companies have the opportunity to present their science and activities to the participants of the Congress. While the 14th European Congress on Biotechnology is not an investment event and therefore companies should not expect to present to large groups of investors, it is an ideal opportunity to present your company’s science and activities to the public sector researchers, industry executives and other members of the European scientific community.

image

Partners:

image

image

image

image

image

image

image

image

image

image

image

Colaborators:

Image

Image

image

image